Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

316 Views

A4. Treatment of antimicrobial resistant infections

Poster Session: Treatment of Antimicrobial Resistant Infections

(P-1530) Evaluation of Phenotypic Cross-Resistance between Cefiderocol and β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US Medical Centers

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Sean T. Nguyen, PharmD

Director, Medical Affairs
Shionogi Inc.
Florham Park, New Jersey, United States

Boudewijn L. DeJonge, PhD (he/him/his)

Director Microbiology
Shionogi Inc.
Florham Park, New Jersey, United States
Jason J. Bryowsky, PharmD, MS

Director, Field Microbiology
Shionogi Inc.
Florham Park, New Jersey, United States
JM

Joshua Maher, PhD

JMI Labs
Liberty City, Iowa, United States
RM

Rodrigo Mendes, PhD

JMI Labs
Liberty City, Iowa, United States
MT

Miki Takemura, n/a

Director, Head of Infectious Diseases 5, Laboratory for Drug Discovery and Disease Research
Shionogi & Co., Ltd
Toyonaka, Osaka, Japan
Yoshinori Yamano, PhD (he/him/his)

Chief Scientific Officer for Infectious Diseases
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan